Nath Bio-Genes Reports Q1 FY27 Growth Amidst Auditor Qualification

Nath Bio-Genes (India) Ltd reported a profit increase of 12% for the quarter ending June 30, 2026, with net profit rising to ₹32.66 crore from ₹29.21 crore in the prior year period. Revenue from operations also saw an uptick.

Reader Takeaway: Revenue and profit growth is positive, but auditor's qualified opinion requires investor attention.

What just happened

Nath Bio-Genes (India) Ltd announced its financial results for the first quarter of fiscal year 2027 (ended June 30, 2026). Standalone revenue from operations grew to ₹322.84 crore from ₹280.17 crore in the same period last year. Net profit increased to ₹32.66 crore, up from ₹29.21 crore year-on-year. Basic and Diluted Earnings Per Share (EPS) improved to ₹17.18 from ₹15.37.

Consolidated figures showed revenue from operations at ₹328.40 crore and net profit at ₹32.26 crore for the same quarter.

Why this matters

The growth in revenue and profit indicates healthy business performance for the quarter. However, a significant point of attention for investors is the 'Basis for qualified opinion' stated in the Independent Auditor's Review Reports for both standalone and consolidated financials. This suggests specific accounting treatments or disclosures that the auditors believe require further explanation or clarification.

The backstory

Nath Bio-Genes (India) Ltd operates primarily in the seed cultivation segment. The company's consolidated results include its 90% equity stake in Nath Bio-Genes (Central Asia) LLC, Uzbekistan. The company has reported zero investor complaints, indicating smooth shareholder communication channels.

What changes now

While the financial performance shows positive momentum, the auditor's qualification necessitates a deeper review by investors into the specific points raised in the auditor's report. This could influence future financial reporting and potential investor sentiment.

Risks to watch

The primary risk highlighted is the 'Basis for qualified opinion' from the auditors. Investors must understand the implications of this qualification, which could relate to accounting policies, estimates, or disclosures. The upcoming Annual General Meeting (AGM) will also be an event to monitor for further updates.

Peer comparison

(No specific peer comparison data was provided in the filing.)

Context metrics (time-bound)

• Q1 FY27 Revenue (Standalone): ₹322.84 crore
• Q1 FY27 Net Profit (Standalone): ₹32.66 crore
• Year-on-Year Profit Growth: 12%

What to track next

Investors should closely examine the auditor's report for the reasons behind the qualified opinion. The company's 33rd AGM, scheduled for September 24, 2026, will be a key event to track for any further announcements or discussions on the financial matters.